Literature DB >> 8357852

Calpain activity alters in rat myocardial subfractions after ischemia or reperfusion.

K Yoshida1, Y Yamasaki, S Kawashima.   

Abstract

To examine whether calpain is activated during ischemic or reperfusion injury, we measured calpain activity of the subfractions of rat myocardia after global ischemia for 60 min or the ischemia followed by 30 min reperfusion by the Langendorff procedure. The myocardial homogenate was fractionated into 600 x g, 10,000 x g and 100,000 x g pellet fractions as well as 10,000 x g supernatant fraction. The supernatant fraction was further subjected to DEAE cellulose and phenyl-Sepharose chromatographies to separate mu- and m-calpains. The m-calpain activity of the DEAE fractions after global ischemia for 60 min was higher but that after ischemia-reperfusion was lower than that of the control. On the other hand, the ischemia-reperfusion but not ischemia by itself raised the calpain activity of the phenyl-Sepharose fraction (mu-calpain) and the 10,000 x g pellet measured at 100 microM and 5 mM Ca2+. Treatment with verapamil but not with ryanodine during ischemia attenuated the increase in m-calpain activity. A dot-blotting analysis of calpain antigenicity showed a decrease in soluble but no change in the particulate fractions after ischemia-reperfusion. An immunoblotting technique did not detect proteolysis of the calpain 80-kDa subunit. These observations suggest that calpain is activated by Ca2+ influx during ischemia and reperfusion without gross changes in its amount. Some unknown processes other than translocation or autolysis are thought to be involved in the alterations.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8357852     DOI: 10.1016/0925-4439(93)90143-o

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  15 in total

1.  Calpain inhibitor I reduces the development of acute and chronic inflammation.

Authors:  S Cuzzocrea; M C McDonald; E Mazzon; D Siriwardena; I Serraino; L Dugo; D Britti; G Mazzullo; A P Caputi; C Thiemermann
Journal:  Am J Pathol       Date:  2000-12       Impact factor: 4.307

Review 2.  Calpain system and its involvement in myocardial ischemia and reperfusion injury.

Authors:  Christiane Neuhof; Heinz Neuhof
Journal:  World J Cardiol       Date:  2014-07-26

3.  Calpain, calpastatin activities and ratios during myocardial ischemia-reperfusion.

Authors:  D Enns; M Karmazyn; J Mair; A Lercher; J Kountchev; A Belcastro
Journal:  Mol Cell Biochem       Date:  2002-12       Impact factor: 3.396

4.  Hypoxia alters the subcellular distribution of protein kinase C isoforms in neonatal rat ventricular myocytes.

Authors:  M Goldberg; H L Zhang; S F Steinberg
Journal:  J Clin Invest       Date:  1997-01-01       Impact factor: 14.808

5.  Transcriptional and translational regulation of calpain in the rat heart after myocardial infarction--effects of AT(1) and AT(2) receptor antagonists and ACE inhibitor.

Authors:  S Sandmann; M Yu; T Unger
Journal:  Br J Pharmacol       Date:  2001-02       Impact factor: 8.739

6.  Calpain inhibitor I reduces colon injury caused by dinitrobenzene sulphonic acid in the rat.

Authors:  S Cuzzocrea; M C McDonald; E Mazzon; H Mota-Filipe; T Centorrino; M L Terranova; A Ciccolo; D Britti; A P Caputi; C Thiemermann
Journal:  Gut       Date:  2001-04       Impact factor: 23.059

7.  Mitogen-activated protein kinase translocates to the nucleus during ischaemia and is activated during reperfusion.

Authors:  Y Mizukami; K i Yoshida
Journal:  Biochem J       Date:  1997-05-01       Impact factor: 3.857

8.  Neuroprotective mechanism of taurine due to up-regulating calpastatin and down-regulating calpain and caspase-3 during focal cerebral ischemia.

Authors:  Ming Sun; Chao Xu
Journal:  Cell Mol Neurobiol       Date:  2007-08-22       Impact factor: 5.046

9.  A new calpain inhibitor protects left ventricular dysfunction induced by mild ischemia-reperfusion in in situ rat hearts.

Authors:  D Takeshita; M Tanaka; S Mitsuyama; Y Yoshikawa; G-X Zhang; K Obata; H Ito; S Taniguchi; Miyako Takaki
Journal:  J Physiol Sci       Date:  2012-12-16       Impact factor: 2.781

10.  Lysophosphatidylcholine-induced myocardial damage is inhibited by pretreatment with poloxamer 188 in isolated rat heart.

Authors:  Makino Watanabe; Takao Okada
Journal:  Mol Cell Biochem       Date:  2003-06       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.